MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2024 International Congress

    Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease

    S. Antipenko, A. Frohlich, M. Sklerov (Chapel Hill, USA)

    Objective: To evaluate transcranial magnetic stimulation (TMS) as a potential therapeutic tool for treatment of orthostatic hypotension (OH) in Parkinson’s disease (PD). Background: Autonomic dysfunction,…
  • 2024 International Congress

    Prognostic role of postganglionic cardiovascular dysfunction in Multiple System Atrophy

    R. Telese, A. Elia, R. Cilia, F. Colucci, V. Leta, A. Braccia, L. Romito, R. Eleopra, G. Devigili (Milan, Italy)

    Objective: To evaluate the role of reduced cardiac postganglionic sympathetic innervation as a prognostic factor in Multiple System Atrophy(MSA) Background: Cardiovascular autonomic dysfunction in MSA…
  • 2024 International Congress

    Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.

    S. O'Shea, Y. Liu, Y. Li, A. Gurnani, J. Dookhy, S. Frank, R. Au, J. Mez, T. Ang, L. Shih (New York, USA)

    Objective: To assess the relationships of long-term blood pressure (BP) measures and incident Parkinson’s disease (PD) in the Framingham Heart Study (FHS) cohort. Background: Long-term…
  • 2024 International Congress

    Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD

    H. Karkourian, L. Atabekyan, N. Nadryan, E. Balian, A. Grigoryan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: To discover whether having probable rapid eye movement sleep behavior disorder (RBD) affects prevalence of particular autonomic symptoms, namely falls, constipation and urinary incontinence…
  • 2024 International Congress

    Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

    G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)

    Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…
  • 2024 International Congress

    Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

    S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)

    Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…
  • 2024 International Congress

    Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

    R. Freeman, I. Biaggioni, R. Vickery, L. Norcliffe-Kaufmann, T. Guerin, M. Bryarly, V. Iodice, M. Rudzniska-Bar, M. Boczarska-Jedynak, C. Oehlwein, C. Shibao, H. Kaufmann (Boston, USA)

    Objective: To assess the long-term safety and tolerability of ampreloxetine in patients with synucleinopathies (MSA, PD, and PAF) and symptomatic neurogenic orthostatic hypotension (nOH) from…
  • 2024 International Congress

    24-Hour Ambulatory Blood Pressure Monitoring and Dipping Patterns in Parkinson’s Disease and Multiple System Atrophy

    D. Tunjungsari, M. Hildaria, I. Jeremia, A. Jody, C. Kathy, A. Tiksnadi (Central Jakarta, Indonesia)

    Objective: To depict 24-hour blood pressure profile, especially dipping patterns, in individuals diagnosed with Parkinson’s Disease (PD) and Multiple System Atrophy (MSA). Background: Both PD…
  • 2024 International Congress

    Efficacy of Audiovisual Neuromodulation in the Treatment of Parkinson’s Disease

    O. Alenikova, L. Parkhach, E. Bоsiakova, G. Zobnina (Minsk, Belarus)

    Objective: To evaluate the AVS effectiveness in depression, anxiety, autonomic disorders and visual dysfunction in PD patients. Background: The severity of non-motor dopa-resistant symptoms in…
  • 2024 International Congress

    Determinants of nocturnal arterial hypertension in Parkinson’s disease patients in Cameroon

    D. Gams Massi, J. Ndjock, A. Magnerou, Y. Mapoure Njankouo (Douala, Cameroon)

    Objective: This study aimed to determine the frequency and factors associated to nocturnal hypertension. Background: Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor…
  • 1
  • 2
  • 3
  • …
  • 22
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley